Jones Soda Co. clarified its strategic direction following the divestiture of its marijuana-derived THC business, reiterating its continued focus on the fast-growing hemp-derived THC (HD9) product line. This includes Mary Jones sodas, shooters, and gummies.
The company emphasized that its HD9 products have demonstrated strong performance, showing four consecutive quarters of sales revenue growth through the first quarter of 2025. This segment is a key part of Jones Soda's adult beverage strategy.
The strategic decision to sell the marijuana-derived THC business allows Jones Soda to increase its focus and expand distribution of its Mary Jones HD9 products. These products are chemically identical to marijuana-derived Delta 9 but are derived from hemp, enabling broader cross-state distribution.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.